丙型肝炎病毒2型作为接受利妥昔单抗联合化疗的B细胞淋巴瘤患者再激活的危险因素。 - Suppr

Suppr

超能文献

HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.

作者信息

Pitini Vincenzo, Sturniolo Giuseppe, Arrigo Carmela, Leonardi Silvana, Pino Salvatrice, Altavilla Giuseppe

出版信息

Br J Haematol. 2010 Jul;150(1):116-8. doi: 10.1111/j.1365-2141.2010.08154.x. Epub 2010 Mar 8.

DOI:10.1111/j.1365-2141.2010.08154.x

PMID:20230413

Abstract

摘要

相似文献

HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.

Br J Haematol. 2010 Jul;150(1):116-8. doi: 10.1111/j.1365-2141.2010.08154.x. Epub 2010 Mar 8.

Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma.

Br J Dermatol. 2006 Nov;155(5):1053-6. doi: 10.1111/j.1365-2133.2006.07451.x.

Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient.

Clin Lab Haematol. 2006 Jun;28(3):211-4. doi: 10.1111/j.1365-2257.2006.00779.x.

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

Ann Hematol. 2004 Dec;83(12):769-74. doi: 10.1007/s00277-004-0899-y. Epub 2004 Aug 25.

[Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab].

Rinsho Ketsueki. 2010 Mar;51(3):213-5.

[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].

Rinsho Ketsueki. 2009 Dec;50(12):1715-9.

Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?

Am J Hematol. 2008 Aug;83(8):673-5. doi: 10.1002/ajh.21214.

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.

Am J Hematol. 2008 Jan;83(1):59-62. doi: 10.1002/ajh.21022.

Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.

Z Gastroenterol. 2010 Feb;48(2):258-63. doi: 10.1055/s-0028-1109782. Epub 2010 Feb 2.

引用本文的文献

Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection.

Sci Rep. 2024 Sep 9;14(1):20981. doi: 10.1038/s41598-024-72082-y.

Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness.

Clin J Gastroenterol. 2024 Jun;17(3):505-510. doi: 10.1007/s12328-024-01944-9. Epub 2024 Apr 8.

Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection.

Cancers (Basel). 2023 May 21;15(10):2852. doi: 10.3390/cancers15102852.

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.

Viruses. 2023 Jan 8;15(1):183. doi: 10.3390/v15010183.

Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia.

Clin J Gastroenterol. 2021 Aug;14(4):1221-1226. doi: 10.1007/s12328-021-01432-4. Epub 2021 May 13.

Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

World J Gastroenterol. 2014 Aug 28;20(32):11054-61. doi: 10.3748/wjg.v20.i32.11054.

Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.

World J Gastroenterol. 2014 Jun 14;20(22):6707-15. doi: 10.3748/wjg.v20.i22.6707.

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Haematologica. 2014 Mar;99(3):489-96. doi: 10.3324/haematol.2013.094318. Epub 2013 Nov 22.

Hepatic encephalopathy associated with cancer or anticancer therapy.

Gastrointest Cancer Res. 2013 Jan;6(1):11-6.

Rituximab-based treatment, HCV replication, and hepatic flares.

Clin Dev Immunol. 2012;2012:945950. doi: 10.1155/2012/945950. Epub 2012 Aug 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验